Navigation Links
CU-Boulder led study of smoking twins points to growing influence of genetic factors
Date:11/16/2011

A new study of twins led by the University of Colorado Boulder shows that today's smokers are more strongly influenced by genetic factors than in the past and that the influence makes it more difficult for them to quit.

"In the past, when smoking rates were higher, people smoked for a variety of reasons," said sociology Professor Fred Pampel, a study co-author. "Today the composition of the smoking population has changed. Smokers are more likely to be hard-core users who are most strongly influenced by genetic factors."

The study showed that adult identical twins sharing a common genetic structure are significantly more likely to quit smoking at the same time compared with fraternal twins who do not share identical genes. This genetic influence has increased in importance among smokers following the initial restrictive legislation on smoking enacted in the United States in the 1970s, Pampel said.

"These days people don't smoke as much for social reasons," Pampel said. "They in fact face criticism for the habit but tend to smoke because of their dependence on nicotine."

The study, to be published in this month's edition of the journal Demography, was led by Associate Professor Jason Boardman and doctoral student Casey Blalock of CU-Boulder's sociology department and Institute of Behavioral Science, and co-authored with Pampel, also of IBS, Peter Hatemi of Pennsylvania State University, Andrew Heath of Washington University in St. Louis and Lindon Eaves of the Medical College of Virginia in Richmond.

Using a database of twins who responded to an extensive health questionnaire, the researchers examined the smoking patterns of 596 pairs of twins, 363 of them identical and 233 of them fraternal. The researchers looked at their smoking patterns from 1960 to 1980 because they wanted to focus on a period of changing views about smoking.

Among identical twins, 65 percent of both twins quit during a two-year timeframe if one twin quit, but among fraternal twins, the percentage dropped to 55 percent, a statistically significant difference that indicates a genetic component at work, Pampel said.

While a specific genetic marker has been hard to identify among those who smoke, certain genetic similarities can be inferred. "If one identical twin quits the other is likely to quit," he said. "And if one twin continues so is the other twin."

The study has implications for current public policies aimed at reducing smoking, which may be becoming less effective, Pampel said.

Since the early and mid 1970s when restrictive anti-smoking legislation began to be enacted in the United States, many smokers have quit. "Prior to 1975 this (potentially genetic) pattern wasn't clear because there were so many smokers."

Two of today's main anti-smoking policies include heavy taxes on cigarettes and vast reductions in the number of public spaces where smoking is allowed, particularly in bars and restaurants, Pampel said.

But with indications that the genetic component is growing, it may be time to treat smoking more like an addiction than a choice, Pampel said. Such a policy shift might include more emphasis on nicotine-replacement therapy and counseling.


'/>"/>

Contact: Fred Pampel
fred.pampel@colorado.edu
303-492-5620
University of Colorado at Boulder
Source:Eurekalert

Related medicine news :

1. CU-Boulder study sheds light on how our brains get tripped up when were anxious
2. Southeast U.S. Still Using High Levels of Antibiotics, Study Shows
3. Women, Younger Men Under-Treated Before Heart Attack: Study
4. Study Finds Link Between Low IQ, Large Waistline
5. Whole-Body Vibration Doesnt Build Bone After All: Study
6. Alcoholics More Likely to Die of Cancer: Study
7. High Doses of Statins Tied to Less Arterial Plaque in Study
8. Women Marathon Runners Have Less Artery Plaque: Study
9. Erectile dysfunction study shows high prevalence of peripheral neuropathy
10. No Benefit From Niacin for Heart Patients in Study
11. Study evaluates normal range systolic bp levels after ischemic stroke and risk of recurrent stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be commonplace ... injury, it occurs when the muscles around the pelvis become inflamed. Over time, ... lower torso, as well as accompanying tenderness and weakness. Without proper intervention, it ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... epigenetic research products enables researchers to pursue the recent RNA methylation “gold rush” ... . In light of the newfound characteristics of N6-methyladenosine, or m6A , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, ... intends to offer shares of common stock in an ... on file with the Securities and Exchange Commission (the ... conditions, and there can be no assurance as to ... as to the actual size or terms of the ...
(Date:3/27/2017)... 2017 To mark the end of Save Your ... leader in digital imaging solutions, will showcase Canon eye care ... New York,s Jacob Javits Center from ... sponsored by the American Optometric Association, is observed annually in ... comprehensive eye exams. In recognition of this observance, Canon ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology: